Mallinckrodt to buy Questcor Pharma for $5.6bn
Ireland-based Mallinckrodt will buy US rival Questcor Pharmaceuticals in a roughly $5.6bn cash-and-stock deal expected to expand the firm's drive in the speciality drugs field, the companies have announced.
Business
• 07 Apr 14
